SCHEMBL29660319

SCHEMBL29660319

[11CH3]Oc1ccc2c(c1)sc1nc(C(=O)Nc3cccnc3)cn12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.52
ALDH1A1 P00352 1/20 0.52
LMNA P02545 2/20 0.52
RXFP1 Q9HBX9 1/20 0.52
TSHR P16473 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
IRAK4 Q9NWZ3 2/20 0.50
MAPT P10636 2/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.50
TP53 P04637 1/20 0.50
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
APP P05067 1/20 0.49
THRB P10828 1/20 0.49
SCD O00767 1/20 0.48
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18548642 1.00 RAB9A (0.52) RAB9AALDH1A1LMNARXFP1TSHR
SCHEMBL29660131 1.00 RAB9A (0.52) RAB9AALDH1A1LMNARXFP1TSHR
SCHEMBL29660220 0.89 LMNA (0.54) RAB9AALDH1A1LMNARXFP1TSHR
SCHEMBL18548672 0.89 LMNA (0.54) RAB9AALDH1A1LMNARXFP1TSHR
SCHEMBL18548611 0.88 LMNA (0.53) RAB9ALMNARXFP1TSHRSMN1; SMN2
SCHEMBL29660162 0.88 LMNA (0.53) RAB9ALMNARXFP1TSHRSMN1; SMN2
SCHEMBL29660216 0.88 RXFP1 (0.57) RAB9AALDH1A1LMNARXFP1TSHR
SCHEMBL18548689 0.88 RXFP1 (0.57) RAB9AALDH1A1LMNARXFP1TSHR
SCHEMBL29660208 0.86 LMNA (0.54) RAB9ALMNARXFP1TSHRSMN1; SMN2
SCHEMBL18548664 0.86 LMNA (0.54) RAB9ALMNARXFP1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11344637-B2 Probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2022-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11344637-B2 Probes for imaging huntingtin protein HTT, HYPK, HSPBP1 RAB9A 1100/4885ALDH1A1 3976/4885LMNA 2021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.